I value being part of the largest and fastest growing user community of its kind in the world
Instem Client
Comparative Medicine Department to Use Instem Solution For Early Research & Development
CONSHOHOCKEN, PA - (BUSINESS WIRE) - December 11, 2007 - Instem, a premier global information solutions provider, announced today that a U.S.-based international biotech organization has placed an order for a new study management, planning, data collection and reporting system for their Research and Development Division’s Department of Comparative Medicine.
Using version 8 of Provantis™, the integrated solution will eliminate the redundant entry of data and simplify the process of defining, reviewing, approving and modifying studies and their related activities. The solution will also simplify the process of checking study outlines against regulatory protocols.
“It’s exciting to see our products supporting a wider area than a traditional GLP Safety Department,” comments Phil Reason, CEO at Instem. “Knowing this solution will be a key element in the mission of one of the largest biotech organizations in the world is a great motivator for all of us at Instem.”
Provantis™ is a modern, fully integrated Windows-based system for organizations and universities of all sizes engaged in non-clinical evaluation studies. The solution suite orchestrates every facet of preclinical drug safety assessment from initial compound receipt through to electronic regulatory submission. Provantis streamlines processes and workflows with straightforward, intuitive functionality for simple and complex studies within a GLP or non-GLP environment.
Instem is a world-leading information solutions provider for the Life Sciences – accelerating drug and chemical development by increasing client productivity and enhancing the processes that lead to safer, more effective products. As well as highly focused departmental and scientific solutions, Instem provides a range of Business Intelligence, Planning, Workflow Management, Dosage Formulation, Document Management and Report Compilation applications. In a highly fragmented Life Sciences IT market, Instem is one of very few organizations that have clearly developed the financial strength necessary to maintain global leadership with established products, while introducing new applications that can deliver the step change in productivity that clients are aggressively pursuing.
For more information on Instem and its solutions, please visit www.instem.com or contact them by email at info@instem.com.
Gary E. Mitchell, VP Global Marketing, Instem US HQ
Tel: (610) 941-0990
Email: gary.mitchell@instem.com
All trademarks used are properties of their respective owners.